triclabendazole has been researched along with Cholangitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jovanovic, I; Popa, D; Radenkovic, D | 1 |
| Al-Haddad, MA; Eloubeidi, MA; MoayyedKazemi, A; Mohamadnejad, M | 1 |
2 other study(ies) available for triclabendazole and Cholangitis
| Article | Year |
|---|---|
Fasciola hepatica as an uncommon cause of cholangitis.
Topics: Anthelmintics; Benzimidazoles; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Common Bile Duct; Dilatation, Pathologic; Fascioliasis; Humans; Male; Middle Aged; Triclabendazole | 2014 |
Biliary fascioliasis diagnosed by EUS.
Topics: Anthelmintics; Benzimidazoles; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Common Bile Duct; Common Bile Duct Diseases; Endosonography; Fascioliasis; Female; Humans; Middle Aged; Triclabendazole | 2016 |